title: Management dilemmas in prostate cancer.
abstract: Large numbers of men have an undetected prostate tumor, but in only a small proportion of cases do these lesions ever become clinically significant. That being so, it will take time to demonstrate the PSA screening or any given treatment strategy has benefit. Meanwhile, patients need help deciding whether to undergo screening and, if cancer is found whether to opt for aggressive treatment.
authors.affiliation: Division of Urology, Department of Medicine, University of Wisconsin Medical School, Madison, USA.
authors.forename: R
authors.initials: R
authors.lastname: Bruskewitz
authors.forename: P P
authors.initials: PP
authors.lastname: Carbone
mesh_terms: D001707:Biopsy, Needle; D003131:Combined Modality Therapy; D017809:Fatal Outcome; D007987:Gonadotropin-Releasing Hormone / Q000627:therapeutic use; D006801:Humans; D008207:Lymphatic Metastasis; D008297:Male; D008875:Middle Aged; D017430:Prostate-Specific Antigen / Q000276:immunology; D011468:Prostatectomy; D011471:Prostatic Neoplasms / Q000175:diagnosis* / Q000276:immunology / Q000473:pathology / Q000601:surgery; D013997:Time Factors
chemical_list: D007987:Gonadotropin-Releasing Hormone; D017430:Prostate-Specific Antigen